1Anderson S Beenner BM. Pathogenesis of diabetic glomeru-lopathy hemodynanic considerations [J]. Diabetes Metab Rev,1998,34:163-177.
2Nagpala PG, Malik AB, Vuong PT, et al. Protein kinase C BI, overexpression augments phorbol ester induced in-crease in endothelial permeability [J]. J Cell Physiol,1996,166:249-255.
8Cawello W,Leonhardt A,Schweer H,etal.Dose proportional pharmacokinetics of alpro-stadil （prostaglandin E1）in healthyvolunteers following intravenous infusion 〔J〕.Br J Clin Pharmacol,1995,40：273～276.
9Anggard E.The biological activities of three metabolites of prostaglandin E1 〔J〕.ActaPhysiol Scand,1996,66：509～510.
10Yasuda H,Maeda K,Sonobe M,et al.Metabolic effect of PGE1 analogue O1206.αCD onnerve Na＋-K＋-ATPase activity of rats with streptozotocin-induced diabetes is mediatedvia cAMP: possible role of cAMP in diabetic neuropathy 〔J〕.Prostaglandins,1994,47：367～378.
2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [ J ]. N Engl J Med, 2010, 362(12) :1090-1101.
3Wang H, Deng JL, Yue J, Li J, Hou YB. Prostaglan- din E1 for preventing the progression of diabetic kidney disease [ J ]. Cochrane Database Syst Rev, 2010, 5 :CD006872.
4Maric C. Vasoactive hormones and the diabetic kidney [ J ]. Scientific World Journal,2008, 8:470-485.
5Mogensen CE. The natural history of diabetic nephropathy in insulinodependent diabetics and the concept of non- glycemic treatment [ J ]. Journ Annu Diabetol Hotel Dieu, 1989:225-246.
6Haffner S M, Lehto S, Ronnemsa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infection [ J ]. N Engl J Med, 1998, 339 (4) : 229-234.
7Bodin S, Chollet C, Goncalves -Mendes N,et al. Kal- likrein protects against microalbuminuria in experimental type I diabetes [ J ]. Kidney Int, 2009, 74 ( 4 ) : 395- 403.
8Itoh Y, Yasui T, Kakizawa H, et al. The therapeutic effect of lipo PGE1 on diabetic neuropathy - changes in endothelin and various angiopathic factors [ J ]. Prosta- glandins Other Lipid Mediat, 2001, 66 (3) : 221-234.
